1. Home
  2. Clinical Operations
  3. eSketamine & Ketamine
  4. KAP – Ketamine Assisted Psychotherapy

KAP – Ketamine Assisted Psychotherapy

Ketamine Assisted Psychotherapy (KAP) refers to the therapeutic use of ketamine, a dissociative anesthetic, in combination with psychotherapy to treat various mental health conditions. KAP has gained attention in recent years for its potential in treating conditions like depression, post-traumatic stress disorder (PTSD), and other mood disorders. Here’s a brief overview:

Frequently Asked Questions

Who sees the KAP patients?

Dr. Herring will provide the initial evaluation, and write the prescription for the Ketamine. She will also work collaboratively with Christina Conrad, LPC (Palo Santo) and her team who will be providing the psychotherapy sessions.

How long are the treatment sessions?

Christina and her team can answer those specific questions with the patient.

How is the Ketamine Administered?

We are using ODT Ketamine, ODT (Oral Disintegrating Tablets) dissolve under the tongue much like Zofran.

Does Insurance Cover KAP?

This version of Ketamine is not covered by insurance and will be a self-pay medicine. Patients can use their insurance to see Dr. Herring if they have a plan we participate with. They would be self pay otherwise.

Do KAP patients need to complete a NPI form?

Patients do not need to submit a NPI form, but they will need to complete the standard new patient paperwork.

KAP Referral Workflow

Christina will send a Charm message to Kiana with the patient’s contact info. Kiana will reach out to schedule the patient with Dr. Herring for a New Patient visit.

Ketamine PMP Reporting Policy

Under Oklahoma law, PMP reporting applies only to dispensing, not administration. “Every pharmacy or dispensing practitioner filling any Schedule II, III, IV, or V prescriptions must report…” (OAC 475:45-1-2). By contrast, “Administer means the direct application of a controlled dangerous substance to the body of a patient… by a practitioner” (63 O.S. §2-101). Therefore:

  • In-clinic IV/IM/oral administration (e.g., KAP infusion session): Not reported to PMP.

  • Take-home supplies (e.g., compounded lozenges, nasal spray, vials dispensed from office): Must be reported to the Oklahoma PMP with all required data fields.

  • Prescriptions filled at an outside pharmacy (e.g., Texas pharmacy dispensing): The dispensing pharmacy reports to its state PMP; no reporting required by our clinic.

Staff must ensure documentation of all administrations in the medical record, and PMP reporting only when dispensing occurs.

Definitions (63 O.S. § 2-101)

“Dispense means to deliver a controlled dangerous substance … including the prescribing, administering, packaging, labeling or compounding necessary to prepare the substance for such distribution.”
Source: Oklahoma Statutes, Title 63 § 2-101—Definitions Justia Law

PMP Reporting Requirement (OAC 475:45-1-2)

“Every pharmacy or dispensing practitioner filling any Schedule II, III, IV, or V prescriptions must report the following information to a central repository…”
Source: Oklahoma Administrative Code, Title 475, Chapter 45, § 1-2 Legal Information Institute Justia Regulations

Oklahoma PMP Requirement (plain language)

“All controlled substances dispensed in or into the State of Oklahoma have to be reported to the Oklahoma PMP.”
Source: Oklahoma Bureau of Narcotics PMP overview obndd.ok.gov


Published: Oct 2, 2023 by Scott Fisher | Updated Nov 19, 2025 @15:50 by Scott Fisher
Was this article helpful?

Related Articles

Leave a Comment